Pharmaco-Therapeutic Challenges in Cancer Biology with Focus on the Immune- System Related Risk Factors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|42|6652-6659

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.42, 2014-12, pp. : 6652-6659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Immune System of Cancer Patients

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 4, 2011-08 ,pp. : 262-274

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Immune System in Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 166-184

Bentham Science Publishers

Access to resources Recommend Favorite

Cystic Fibrosis and the Innate Immune System: Therapeutic Implications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 1, 2011-03 ,pp. : 8-22

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaco(epi)genomics in ovarian cancer

By Paige Adam JW   Brown Robert  

Pharmacogenomics, Vol. 9, Iss. 12, 2008-12 ,pp. : 1825-1834

Future Medicine

Access to resources Recommend Favorite

Genetic + immune factors increase nevirapine hypersensitivity risk

By  

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite